https://www.selleckchem.com/pr....oducts/crenolanib-cp
001). A total of 22 (3.6%) deaths occurred, 9% of men vs. 2% of women (P0.001). Multivariate modelling revealed that mortality was associated with age [adjusted hazard ratio (AHR)=1.07 per year increase; 95% confidence interval (CI) 1.01-1.13], male gender (AHR=2.57; 95% CI 1.06-6.23) and time-updated CD4 counts (AHR=0.67 per 100 cell increment; 95% CI 0.52-0.88). Virological failure was not associated with mortality (P=0.762). Female patients receiving ART in rural Uganda were three times more likely to be hospitalized
Like
Comment
Share
